Advertisement

Organisation › Details
Bpifrance
Bpifrance, a subsidiary of Caisse des Dépôts and the French State, is a trusted partner of entrepreneurs which provides companies with credit, collateral and equity financing support from start up through to stock exchange listing. Bpifrance also provides guidance services and enhanced support for innovation, external growth and export, in partnership with Business France. Bpifrance offers companies a continuum of financing for each key stage of their development and an offer adapted to specific regional features. With 47 regional offices (90% of decisions are made regionally), Bpifrance offers entrepreneurs a tool for economic competitiveness. Bpifrance works in support of the public policies pursued nationally and regionally by the French government, to meet three objectives: • support the growth of businesses; • prepare for future competitiveness; • contribute to the development of a favourable ecosystem for entrepreneurship. With Bpifrance, companies have a strong and effective local contact to meet all their financial, innovation and investment needs. *
![]() |
Start | 2013-07-03 renamed before |
Group | France (govt) | |
Predecessor | OSEO S.A. | |
![]() |
Industry | business development (state/region) |
Industry 2 | finance | |
![]() |
Person | Dufourcq, Nicolas (France (govt) 202109 CEO of Bpifrance) |
Person 2 | Berthuin, Jeremy (France (govt) 201701 Head of Healthcare Sector at Bpifrance) | |
![]() |
Region | Île-de-France (region) |
Country | France | |
Street | 27–31 avenue du Général Leclerc | |
City | 94710 Maisons-Alfort CEDEX | |
Tel | +33-1-4179-8000 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2025-01-11 |
Advertisement

More documents for France (govt)
- [1] AdBio Partners SAS. (6/18/24). "Press Release: Inserm Transfert and AdBio Partners Launch AndzonBio". Paris....
- [2] Evotec SE. (5/30/23). "Press Release: Evotec, Inserm, Lille University Hospital and Inserm Transfert Enter Collaboration to Identify Novel Therapeutic Targets in Obesity and Metabolic Diseases". Hamburg....
- [3] SurgeCare SAS. (3/27/24). "Press Release: Surge Announces Closing of a €7.5 Million Fundraising Round to Decrypt the Immune System and Transform Precision Medicine". Paris....
- [4] Global Bioenergies S.A.. (10/4/23). "Press Release: French Government Awards Global Bioenergies €16.4 Million to Help Fund Construction of the World’s First Biosourced Isobutene Plant". Évry....
- [5] EverImmune. (9/19/23). "Press Release: EverImmune Secures €3.5 Million in Financing from Bpifrance". Villejuif....
- [6] AdBio Partners SAS. (7/11/23). "Press Release: AdBio Partners Strengthens Its Management Team and Promotes Clément Bertholet as Partner". Paris....
- [7] Biper Therapeutics SAS. (2/14/23). "Press Release: Biper Therapeutics Raises €1.25 Million in Seed Funding to Develop First-in-Class Small Molecules to Treat Gastrointestinal Cancers". Strasbourg....
- [8] Theranexus S.A.. (10/20/22). "Press Release: Theranexus and Inserm Transfert Sign a Strategic Alliance to Identify Advanced Therapy Drug Candidates for Rare Neurological Diseases". Lyon....
- [9] AdBio Partners SAS. (5/3/22). "Press Release: AdBio Partners Welcomes Inserm Transfert as Investor in Second Fund – AFB Fund II". Paris....
- [10] Hemerion Therapeutics SAS. (4/14/22). "Press Release: Hemerion Therapeutics successfully raises over €3.5 million: a new hope for the treatment of brain cancer". Villeneuve d’Ascq....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top